| Configuration: AlphaGenome all outputs, quantile, maximum (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.583 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceAlphaGenome on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'AlphaGenome', bar label |
|---|
| Configuration: AlphaMissense precomputed scores (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.924 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceAlphaMissense on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'AlphaMissense', bar label |
|---|
| Configuration: DNABERT-2 117M, CLS embedding L2 distance (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.449 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceDNABERT2 on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'DNABERT2', bar label |
|---|
| Configuration: ESM1b 650M log-likelihood ratio, Brandes et al. pipeline (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.8 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceESM1b on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'ESM1b', bar label |
|---|
| Configuration: ESM1v model 1 log-likelihood ratio, Brandes et al. pipeline (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.769 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceESM1v on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'ESM1v', bar label |
|---|
| Configuration: ESM2 650M log-likelihood ratio, Brandes et al. pipeline (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.818 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceESM2 on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'ESM2', bar label |
|---|
| Configuration: Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.835 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceEvo2 on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'Evo2', bar label |
|---|
| Configuration: GPN-MSA precomputed hg38 scores (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.896 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceGPN-MSA on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'GPN-MSA', bar label |
|---|
| Configuration: Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.664 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceNucleotide Transformer on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'Nucleotide Transformer', bar label |
|---|
| Configuration: PhyloGPN, official example code (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.689 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcePhyloGPN on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'PhyloGPN', bar label |
|---|
| Configuration: PhyloP 100-way vertebrate (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.868 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcePhyloP on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'PhyloP', bar label |
|---|
| Configuration: PrimateAI-3D precomputed scores (Lu et al. 2025) | Protocol: ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) Dataset subset: Lu et al. 2025 ClinVar benchmark: Missense & Intron (Non-splice) (Figure 1) | 0.905 AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcePrimateAI-3D on ClinVar Missense & Intron (Non-splice) SNVs (Lu et al. 2025 Figure 1) lu-hetero-20261019-protocol-clinvar-variant-type-auroc Aggregation: Not reported Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) · Figure 1 (page 8), column 3, panel 2 'Missense & Intron (Non-splice) (N=255, %P=17.91%)', row 'PrimateAI-3D', bar label |
|---|